Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators

Circulation

Volumn 93, Issue 4, 1996, Pages 753-762

  Villacastín, Julián ^a   Almendral, Jesús ^a,b   Arenal, Angel ^a   Albertos, José ^a   Ormaetxe, José ^a   Peinado, Rafael ^a   Bueno, Héctor ^a   Merino, Jose L ^a   Pastor, Agustín ^a   Medina, Olga ^a   Tercedor, Luis ^a   Jiménez, Francisco ^a   Delcán, Juan Luis ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

defibrillation; prognosis; survival; tachyarrhythmias

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVERSION; DEFIBRILLATION; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

EID: 9044254929     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.4.753     Document Type: Article

References (59)

1. Mirowski M, Reid PR, Winkle RA, Mower MM, Watkins L, Stinson EB, Griffith LSC, Kallman CH, Weisfeldt ML. Mortality in patients with implanted automatic defibrillators. Ann Intern Med. 1983;98:585-588.
2. Echt DS, Armstrong K, Schmidt P, Oyer PE, Stinson EB, Winkle RA. Clinical experience, complications and survival in 70 patients with the automatic implantable cardioverter defibrillator. Circulation. 1985;71:289-296.
3. Marchlinski FE, Flores BR, Buxton AE, Hargrove WC, Addonizio VP, Stephenson LW, Harken AH, Doherty JU, Grogan EW Jr, Josephson ME. The automatic implantable cardioverter defibrillator: efficacy, complications, and device failures. Ann Intern Med. 1986;104:481-488.
4. Fogoros RN, Fiedler SB, Elson JJ. The automatic implantable cardioverter-defibrillator in drug refractory ventricular tachyarrhythmias. Ann Intern Med. 1987;107:635-641.
5. Tchou PJ, Kadri N, Anderson J, Caceres JA, Jazayeri M, Akhtar M. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med. 1988;109:529-534.
6. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, Schmidt P, Shipman T. Long-term outcome with the automatic implantable defibrillator. J Am Coll Cardiol. 1989;16:1353-1361.
7. Gross J, Zilo P, Ferrick K, Fisher JD, Furman S. Sudden death mortality in implantable cardioverter defibrillator patients. PACE Pacing Clin Electrophysiol. 1991;14:250-254.
8. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol. 1990;16:381-386.
9. Fogoros RN. The effect of the implantable cardioverter defibrillator on sudden death and on total survival. PACE Pacing Clin Electrophysiol. 1993;3:II-506-II-510.
10. Furman S. ICD benefit. PACE Pacing Clin Electrophysiol. 1989;12: 399-400.
11. Connolly SJ, Yusuf S. Evaluation of the implantable cardioverter defibrillator in survivors of cardiac arrest: the need for randomized trials. Am J Cardiol. 1992;69:959-962.
12. Kim SG. Implantable defibrillator: does it really prolong life? how can we prove it? Am J Cardiol. 1993;71:1213-1218.
13. Sweeney MO, Ruskin JN. Mortality benefits and the implantable cardioverter defibrillator. Circulation. 1994;89:1851-1858.
14. Fogoros R, Elson J, Bonnet C. Actuarial incidence and pattern of shocks following implantation of the automatic implantable cardioverter defibrillator. PACE Pacing Clin Electrophysiol. 1989;12: 1465-1473.
15. Zilo P, Gross J, Benedek ZM, Fisher J, Furman S. Occurrence of ICD shocks and patient survival. PACE Pacing Clin Electrophysiol. 1991;14:273-279.
16. Tchou P, Axtell K, Keim S, Anderson AI, Troup P, Jazayeri M, Avitall B, Akhtar M. Does reception of appropriate shocks from implantable cardioverter defibrillator affect survival? PACE Pacing Clin Electrophysiol. 1991;14:1929-1934.
17. Gross JN, Song SL, Buckingham T, Furman S, and the Bilitch Registry Group. Influence of clinical characteristics and shock occurrence on ICD patient outcome: a multicenter report - the Bilitch Registry Group. PACE Pacing Clin Electrophysiol. 1991;14: 1881-1886.
18. Levine JH, Mellits ED, Baumgardner RA, Veltri EP, Mower M, Grunwald L, Guarnieri T, Aarons D, Griffith LS. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation. 1991;84: 558-564.
19. Metha D, Saksena S, Krol R. Survival of implantable cardioverter defibrillator recipients: role of left ventricular function and its relationship to device use. Am Heart J. 1992;124:1608-1614.
20. Grimm W, Flores BT, Marchlinski FE. Shock occurrence and survival in 241 patients with implantable cardioverter defibrillator therapy. Circulation. 1993;87:1880-1888.
21. Fogoros RN, Elson JJ, Bonnet CA. Survival of patients who have received appropriate shocks from their implantable defibrillators. PACE Pacing Clin Electrophysiol. 1991;14:1842-1845.
22. Buxton AE, Waxman HL, Marchlinski FE, Untereker WJ, Waspe LE, Josephson ME. Role of triple extrastimuli during electrophysiologic study in patients with documented sustained ventricular tachyarrhythmias. Circulation. 1984;69:532-540.
23. Fromer M, Brachmann J, Block M, Siebels J, Hoffmann E, Almendral JM, Ohm O, Den Dulk K, Coumel P, Camm J, Touboul P. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator: results of a European multicenter study of 102 implants. Circulation. 1992;86:363-374.
24. Heisel A, Neuzner J, Himmrich E, Pitschner HP, Liebrich A, Jung J, Sen S. Safety of antitachycardia pacing in patients with implantable cardioverter defibrillators and severely depressed left ventricular function. Pacing Clin Electrophysiol. 1995;18(pt III): 137-141.
25. Rabinovich R, Muratore C, Iglesias R, Gonzalez M, Serafrica M, Lipreandi AS. Results of delivery therapy for VT or VF in patients with third generation implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 1995;18(pt III):133-136.
26. Davy JM, Fain ES, Dorian P, Winkle RA. The relationship between successful defibrillation and delivered energy in open-chest dogs: reappraisal of the 'defibrillation threshold' concept. Am J Cardiol. 1987;113:77-83.
27. Echt DS, Lee JT, Hammon JW. Implantation and intraoperative assessment of antitachycardia devices. In: Saksena S, Goldschlager N, eds. Electrical Therapy for Cardiac Arrhythmias. Philadelphia, Pa: WB Saunders; 1990:489-515.
28. Wetherbee JN, Chapman PD, Troup PJ, Veseth-Rogers J, Thakur RK, Almassi GH, Olinger GN. Long-term internal cardiac defibrillation threshold stability. PACE Pacing Clin Electrophysiol. 1989;12: 443-450.
29. Wood MA, Stambler BS, Damiano RJ, Greenway P, Ellenbogen KA, and the Guardian ATP 4210 Multicenter Investigators Group. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. J Am Coll Cardiol. 1994;24:1692-1699.
30. Swerdlow CD, Winkle RA, Mason JW. Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med. 1983;308: 1436-1442.
31. Nisam S, Mower M, Moser S. ICD clinical update: first decade, initial 10,000 patients. PACE Pacing Clin Electrophysiol. 1991;14: 255-262.
32. Wilber JD, Garan H, Finkelstein D, Kelly E, Newell J, McGovern B, Ruskin JN. Out-of-hospital cardiac arrest: use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med. 1988;318:19-24.
33. Poole JE, Mathisen TL, Kudenchuck PJ, McAnulty JH, Swerdlow CD, Bardy GH, Greene HL. Long-term outcome in patients who survive out-of-hospital cardiac fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups. J Am Coll Cardiol. 1990;16:657-665.
34. Kim SG. Management of survivors of cardiac arrest: is electrophysiologic testing obsolete in the era of implantable defibrillators? J Am Coll Cardiol. 1990;16:756-762.
35. Kim SG, Fisher JD, Choue CW, Gross J, Roth J, Ferrick KJ, Brodman R, Furman S. Influence of left ventricular function on outcome of patients treated with implanted defibrillators. Circulation. 1992;85:1304-1310.
36. Kim SG, Maloney JD, Pinski SL, Choue CW, Ferrick KJ, Roth JA, Gross J, Brodman R, Furman S, Fisher JD. Influence of left ventricular function on survival and mode of death after implantable defibrillator therapy: Cleveland Clinic Foundation and Montefiore Medical Center experience. Am J Cardiol. 1993;72:1263-1267.
37. Myerburg RJ, Luceri RM, Thurer R, Cooper DK, Zaman L, Interian A, Fernandez J, Cox M, Glicksman F, Castellanos A. Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 1989;14:508-514.
38. Kluger J, Veronneau J, Fisher J. Cluster shocks: a strong predictor of subsequent mortality in patients with internal cardioverter defibrillator. Pacing Clin Electrophysiol. 1995;18:II-845. Abstract.
39. Kohno T, Bhandari AK, Park Y, Bollmann A, Lerman RD, Cannom DS. Cluster shocks in patients with third generation implantable cardioverter defibrillators: frequency, mechanisms and clinical significance. Pacing Clin Electrophysiol. 1995;18:II-846. Abstract.
40. Sweeney MO, Guy M, McGovern BA, Garan H, Ruskin JN. Sudden cardiac death in patients with third generation implantable cardioverter defibrillator: relationship to clinical variables, lead configuration, and spontaneous ventricular therapies. Circulation. 1994;90(suppl):I-654. Abstract.
41. Dolack GL, for the CASCADE Investigators. Clinical predictors of implantable cardioverter-defibrillator shocks: results of the CASCADE Trial. Am J Cardiol. 1994;73:237-241.
42. Lessmeier TJ, Lehmann MH, Steinman RT, Fromm BS, Akhtar M, Calkins H, DiMarco JP, Epstein AE, Estes NA, Fogoros RN, Marchlinski FE, Wilber D. Implantable cardioverter-defibrillator therapy in 300 patients with coronary artery disease presenting exclusively with ventricular fibrillation. Am Heart J. 1994;128: 211-218.
43. Kudenchuk A, Bardy GH, Dolack GL, Poole JE, Anderson J, Troutman C. Women with ventricular tachyarrhythmias: characteristics and outcome of treatment with implanted cardioverter defibrillators. Circulation. 1994;90:I-665. Abstract.
44. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S, and the Israeli SPRINT Investigators. In-hospital and 1-year mortality in 1524 women after myocardial infarction: comparison with 4315 men. Circulation. 1991;83:484-491.
45. Jenkins JS, Flaker GC, Nolte B, Price LA, Morris D, Kurz J, Petroski GF. Causes of higher in-hospital mortality in women than in men after acute myocardial infarction. Am J Cardiol. 1994;73: 319-322.
46. Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction: biology or methodology? JAMA. 1990;263:1092-1096.
47. Lincoff AM, Califf RM, Elli SG, Sigmon KN, Lee KL, Leimberg JD, Topol EF, for the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? J Am Coll Cardiol. 1993;22:1780-1787.
48. Marrugat J, Antó JM, Sala J, Masiá R, and the REGICOR Investigators. Influence of gender in acute and long term mortality after a first myocardial infarction. J Clin Epidemiol. 1994;47:111-118.
49. Tobin J, Wassertheil-Smoller S, Wexler J, Steingart R, Budner N, Lense L, Wachspress J. Sex bias in considering coronary bypass surgery. Ann Intern Med. 1987;107:19-25.
50. Steingart R, Packer M, Hamm P, Coglianese M, Gersh B, Geltman E, Sollano J, Katz S, Moyé L, Basta L. Sex differences in the management of coronary artery disease. N Engl J Med. 1991;325: 226-230.
51. Ayanian J, Epstein A. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 1991;325:221-225.
52. Khan S, Nessim S, Gray R, Czer L, Chaux A, Matloff J. Increased mortality of women in coronary artery bypass surgery: evidence for a referral bias. Ann Intern Med. 1990;112:561-567.
53. Healy B. The Yentl syndrome. N Engl J Med. 1991;325:274-275.
54. Kannel WB, Doyle JT, McNamara PM, Quickenton P, Gordon T. Precursors of sudden coronary death: factors related to the incidence of sudden death. Circulation. 1975;51:606-613.
55. ™ automatic cardioverter defibrillator clinical update: 14 years experience in over 34,000 patients. Pacing Clin Electrophysiol. 1995:18(pt II):142-147.
56. The PCD Investigator Group. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter defibrillator implanted with or without thoracotomy: an international multicenter study. J Am Coll Cardiol. 1994;23:1521-1530.
57. Grimm W, Flores BF, Marchlinski FE. Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator. Am J Cardiol. 1993;71:1415-1418.
58. Maloney J, Masterson M, Khoury D, Trohman R, Wilkof B, Simmons T, Morant V, Castle L. Clinical performance of the implantable cardioverter defibrillator: electrocardiographic documentation of 101 spontaneous discharges. PACE Pacing Clin Electrophysiol. 1991;14:280-285.
59. Hook BG, Callans DJ, Kleiman RB, Flores BT, Marchlinski FE. Implantable cardioverter defibrillator therapy in the absence of significant symptoms: rhythm diagnosis and management aided by stored electrograms analysis. Circulation. 1993;87:1897-1906.